Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers May 24, 2017
Pharmacy Choice - Pharmaceutical News - Analyzing the Generic Drugs Sector of the US Pharmaceutical Industry 2017 - Research and Markets - May 24, 2017

Pharmacy News Article

 3/20/17 - Analyzing the Generic Drugs Sector of the US Pharmaceutical Industry 2017 - Research and Markets

DUBLIN(BUSINESS WIRE) Research and Markets has announced the addition of the "Analyzing the Generic Drugs Sector of the US Pharmaceutical Industry 2017" report to their offering.

The United States is the biggest generic drugs market in the world. In fact, nearly 80% of the prescriptions written in the US are for generic drugs.

Analyzing the Generic Drugs Sector of the US Pharmaceutical Industry 2017 - a comprehensive coverage of the generic drugs market in the United States. Beginning with a sectional description on generic drugs, the report covers topics such as the impact of the generics sector on major pharma companies, R&D strategies being implemented by major pharma companies in the generics sector, the long debate over generic drugs versus branded drugs, and much more - a cost analysis of branded drugs versus generic drugs being a highlight.

An overview of the global generics sector builds up the scene for the analysis of the US generics industry. The all-important Hatch-Waxman Framework, the DEFRA Regulation, and other recent regulatory measures are included in this analysis, along with the emerging issue of promoting generic drug competition in the US Market.

Being a major section of the report, Promoting Generic Drug Competition in the US Market covers topics such as issues with the FDA Approval Process, the role of the Orange Book, the positive and negative outcomes of the Hatch Waxman Act, the manipulation of this act, promoting methods for generic drug availability, amongst other points of discussion.

Strategies for survival employed by branded manufacturers, the role of generic drugs in lowering US drug re-importation, a case study on generic antidepressants, the approval of the generic version of GSK's drug Coreg, the introduction of Bill S.438, and the substantial move by Blue Cross in major changes to its drug plans, are discussed and analyzed in this report.

We also include a Porter's Five Forces analysis of the US Generic Drugs Industry.

Analysis of major industry players such as Teva Pharmaceutical Industry, Mylan N.V., Sandoz, Sanofi SA and others concludes this comprehensive research report.

Key Topics Covered:

A. Executive Summary

B. What are Generic Drugs?

C. Overview of the Global Generics Sector

D. Generics Industry in the United States

E. Generics Industry in the US: Porter's Five Forces Strategy Analysis

F. Pricing and Reimbursement of Generics in the US

G. Entry of Authorized Generics in the US Pharmaceutical Industry

H. Promoting Generic Drug Competition in the US Market

I. Strategies for Branded Manufacturers

J. Generic Drugs' Role in US Drug Re-importation

K. Case Study: Generic Antidepressants

L. Case Study: Major Change to Drug Plan by Blue Cross

M. Leading Industry Players

- Allergan Plc

- Mylan N.V.

- Par Pharmaceutical Companies, Inc.

- Sandoz International GmbH

- Sanofi SA

- Teva Pharmaceutical Industries

For more information about this report visit http://www.researchandmarkets.com/research/8c46pw/analyzing-the

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Related Topics: Pharmaceuticals, Generic Drugs

Source: Research and Markets



Copyright Business Wire 2017

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Last Chance
May 24: Update on the Treatment for Major Depressive Disorder
Last Chance
May 25: Acne Vulgaris: Comprehensive Pharmaceutical Care
May 26: Dispensing Controlled Substances in Today’s Pharmacy
May 30: The American Geriatric Society Beers Criteria: Implications for Pharmacy Practice
May 31: Medication Safety & Drug Safety Alerts
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415